Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive Therapy - EP4219687

The patent EP4219687 was granted to Juno Therapeutics on Aug 14, 2024. The application was originally filed on Apr 23, 2015 under application number EP23164036A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4219687

JUNO THERAPEUTICS
Application Number
EP23164036A
Filing Date
Apr 23, 2015
Status
Granted And Under Opposition
Jul 12, 2024
Grant Date
Aug 14, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AMMELBURGMay 14, 2025FISH & RICHARDSON PCADMISSIBLE
ARROWHOUSEMay 14, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
POHLMANOct 29, 2024POHLMANADMISSIBLE

Patent Citations (51) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO1991US08442
DESCRIPTIONWO1994US05601
DESCRIPTIONEP0452342
DESCRIPTIONEP2537416
DESCRIPTIONUS2002131960
DESCRIPTIONUS2003170238
DESCRIPTIONUS2004082012
DESCRIPTIONUS2011003380
DESCRIPTIONUS2013287748
DESCRIPTIONUS2015024411
DESCRIPTIONUS4235871
DESCRIPTIONUS4452773
DESCRIPTIONUS4501728
DESCRIPTIONUS4690915
DESCRIPTIONUS4795698
DESCRIPTIONUS4837028
DESCRIPTIONUS5019369
DESCRIPTIONUS5087616
DESCRIPTIONUS5200084
DESCRIPTIONUS5219740
DESCRIPTIONUS5506121
DESCRIPTIONUS6040177
DESCRIPTIONUS6103493
DESCRIPTIONUS6207453
DESCRIPTIONUS6451995
DESCRIPTIONUS7446190
DESCRIPTIONUS7482000
DESCRIPTIONUS7981632
DESCRIPTIONWO0014257
DESCRIPTIONWO02077018
DESCRIPTIONWO2009072003
DESCRIPTIONWO2010033140
DESCRIPTIONWO2013011011
DESCRIPTIONWO2013126726
DESCRIPTIONWO2014076277
OPPOSITIONEP4219687
OPPOSITIONUS2013287748
OPPOSITIONWO02077029
OPPOSITIONWO2009091826
OPPOSITIONWO2012079000
OPPOSITIONWO2013192294
OPPOSITIONWO2014012001
OPPOSITIONWO2014031687
OPPOSITIONWO2014127261
OPPOSITIONWO2014186469
OPPOSITIONWO2015164675
SEARCHWO2007117602
SEARCHWO2009072003
SEARCHWO2013011011
SEARCHWO2013038272
SEARCHWO2013124474

Non-Patent Literature (NPL) Citations (88) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALONSO-CAMINO et al., Mol Ther Nucl, (20130000), page e93
DESCRIPTION- AMADORI, A et al., Nature Med., (19950000), vol. 1, pages 1240 - 1241
DESCRIPTION- BAUM et al., Molecular Therapy: The Journal of the American Society of Gene Therapy, (20060000), vol. 13, pages 1050 - 1063
DESCRIPTION- BES et al., J. Biol. Chem., (20030000), vol. 278, pages 14265 - 14273
DESCRIPTION- BORIS-LAWRIETEMIN, Cur. Opin. Genet. Develop., (19930000), vol. 3, pages 102 - 109
DESCRIPTION- BRASH et al., Mol. Cell Biol, (19870000), vol. 7, pages 2031 - 2034
DESCRIPTION- BURNS, Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 8033 - 8037
DESCRIPTION- CAGGIARI et al., Cytometry, (20010000), vol. 46, no. 4, pages 233 - 237
DESCRIPTION- CARLENS et al., Exp Hematol, (20000000), vol. 28, no. 10, pages 1137 - 46
DESCRIPTION- CAVALIERI et al., Blood, (20030000), vol. 102, no. 2, pages 1637 - 1644
DESCRIPTION- CHEN, Blood, (20010701), vol. 98, no. 1, pages 156 - 64
DESCRIPTION- CHICAYBAM et al., PLoS ONE, (20130000), vol. 8, no. 3, page e60298
DESCRIPTION- CHO et al., Lab Chip, (20100000), vol. 10, pages 1567 - 1573
DESCRIPTION- CLEMENTI, M et al., Hum. Genet, (19990000), vol. 105, pages 337 - 342
DESCRIPTION- COHEN et al., J Immunol., (20050000), vol. 175, pages 5799 - 5808
DESCRIPTION- FOULDS et al., J Immunol., (20020000), vol. 168, no. 4, pages 1528 - 1532
DESCRIPTION- GODIN, J Biophoton, (20080000), vol. 1, no. 5, pages 355 - 376
DESCRIPTION- HACKETT et al., Molecular Therapy: The Journal of the American Society of Gene Therapy, (20100000), vol. 18, pages 1748 - 1757
DESCRIPTION- HERMAN et al., J. Immunological Methods, (20040000), vol. 285, no. 1, pages 25 - 40
DESCRIPTION- HOFFMAN et al., Transplantation, (20020000), vol. 74, no. 6, pages 836 - 845
DESCRIPTION- JOHNSTON, Nature, (19900000), vol. 346, pages 776 - 777
DESCRIPTION- KLEBANOFF et al., J Immunother, (20120000), vol. 35, no. 9, pages 651 - 660
DESCRIPTION- KOCHENDERFER et al., J. Immunotherapy, (20090000), vol. 32, no. 7, pages 689 - 702
DESCRIPTION- LI, Nat Biotechnol., (20050000), vol. 23, pages 349 - 354
DESCRIPTION- LUPTON S. D. et al., Mol. and Cell Biol, (19910000), vol. 11, page 6
DESCRIPTION- MANURI et al., Hum Gene Ther, (20100000), vol. 21, no. 4, pages 427 - 437
DESCRIPTION- Metastasis Research Protocols, vol. 2
DESCRIPTION- Methods in Molecular Medicine, vol. 58
DESCRIPTION- MILLER, A.D., Human Gene Therapy, (19900000), vol. 1, pages 5 - 14
DESCRIPTION- MILLERROSMAN, BioTechniques, (19890000), vol. 7, pages 980 - 990
DESCRIPTION- MUHONEN, T., J Immunother Emphasis Tumor Immunol., (19940100), vol. 15, no. l, pages 67 - 73
DESCRIPTION- MULLEN et al., Proc. Natl. Acad. Sci. USA., (19920000), vol. 89, page 33
DESCRIPTION- PARK et al., Trends Biotechnol, (20111100), vol. 29, no. 11, pages 550 - 557
DESCRIPTION- PARKHURST et al., Clin Cancer Res, (20090000), vol. 15, pages 169 - 180
DESCRIPTION- RABENSTEIN et al., J Immunol., (20140317), page 1302725
DESCRIPTION- RICH et al., Analytical Biochemistry, (20090000), vol. 386, pages 194 - 216
DESCRIPTION- RIDDELL et al., Human Gene Therapy, (19920000), vol. 3, pages 319 - 338
DESCRIPTION- ROSENBERG, Nat Rev Clin Oncol., (20110000), vol. 8, no. 10, pages 577 - 85
DESCRIPTION- ROSENBERG SA et al., N Engl JMed, (19880000), vol. 319, pages 1676 - 1680
DESCRIPTION- SADELAIN et al., Cancer Discov, (20130400), vol. 3, no. 4, pages 388 - 398
DESCRIPTION- SCARPA et al., Virology, (19910000), vol. 180, pages 849 - 852
DESCRIPTION- SHARMA et al., Molec Ther Nucl Acids, (20130000), vol. 2, page e74
DESCRIPTION- STEMBERGET et al., PLoS One, vol. 7, page 35798
DESCRIPTION- SZOKA et al., Ann. Rev. Biophys. Bioeng, (19800000), vol. 9, page 467
DESCRIPTION- TERAKURAET, Blood, (20120000), vol. 1, pages 72 - 82
DESCRIPTION- THEMELI et al., Nat Biotechnol., (20130000), vol. 31, no. 10, pages 928 - 933
DESCRIPTION- TSUKAHARA, Biochem Biophys Res Commun, (20130000), vol. 438, no. 1, pages 84 - 9
DESCRIPTION- TURTLE et al., Curr. Opin. Immunol, (20121000), vol. 24, no. 5, pages 633 - 39
DESCRIPTION- VAN TEDELOO, Gene Therapy, (20000000), vol. 7, no. 16, pages 1431 - 1437
DESCRIPTION- VARELA-ROHENA et al., Nat Med., vol. 14, pages 1390 - 1395
DESCRIPTION- VERHOEYEN et al., Methods Mol Biol, (20090000), vol. 506, pages 115 - 126
DESCRIPTION- WADWA et al., J. Drug Targeting, (19950000), vol. 3, page 1 1 1
DESCRIPTION- WANG et al., J. Immunother, (20120000), vol. 35, no. 9, pages 689 - 701
DESCRIPTION- WIGLER et al., Cell II, vol. 223, page 1977
DESCRIPTION- WILSON et al., Proc.Natl.Acad.Sci.USA, (20010000), vol. 98, pages 3750 - 3755
DESCRIPTION- WU et al., Cancer, (20120318), no. 2, pages 160 - 75
OPPOSITION- D12a - D12a Screenshot of Webpage from The Cancer Journal, showing publication of D12
OPPOSITION- Katharina Drechsel, Lehmann Constance, Bohnenkamp Hermann, Assenmacher Mario, Huppert Volker, Johnston Ian, Andrew Kaiser, Mauer Daniela, Mockel-Tenbrink Nadine, Lehmann Constanze, Assemacher Mario, Andrew Kaiser, Adair Jennifer E, Porter Shaina N, Porteus Matthew H, Kiem Hans-Peter, "Towards Automated Manufacturing of Clinical Scale Gene-Modifi ed T Cells", Molecular Therapy 22, Supplement 1, page S286, Molecular Therapy 22, Supplement 1, (20200331), XP055681179
OPPOSITION- Kochenderfer J N; Feldman S A; Zhao Y; Xu H; Black M A; Morgan R A; Wilson W H; Rosenberg S A, "Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor", Journal of immunotherapy, Raven Press, US, US , (20090901), vol. 32, no. 7, ISSN 1524-9557, pages 689 - 702, XP009133189
OPPOSITION- Isakov Noah, "Immunoreceptor tyrosine-based activation motif (ITAM), a unique module linking antigen and Fc receptors to their signaling cascades", Journal of Leukocyte Biology, Society for Leukocyte Biology, US, US , (19970101), vol. 61, no. 1, doi:10.1002/jlb.61.1.6, ISSN 0741-5400, pages 6 - 16, XP093280222
OPPOSITION- Turtle Cameron J., "Chimeric antigen receptor modified T cell therapy for B cell malignancies", INTERNATIONAL JOURNAL OF HEMATOLOGY., ELSEVIER SCIENCE PUBLISHERS., NL, NL , (20140201), vol. 99, no. 2, doi:10.1007/s12185-013-1490-x, ISSN 0925-5710, pages 132 - 140, XP093280200
OPPOSITION- Krainer Julie; Siebenhandl Sandra; Weinhäusel Andreas, "Systemic autoinflammatory diseases", JOURNAL OF AUTOIMMUNITY, LONDON, GB, GB , (20200201), vol. 109, doi:10.1016/j.jaut.2020.102421, ISSN 0896-8411, XP086125304
OPPOSITION- Boonpiyathad Tadech; Sözener Zeynep Celebi; Satitsuksanoa Pattraporn; Akdis Cezmi A., "Immunologic mechanisms in asthma", Seminars in immunology, W.B. SAUNDERS COMPANY, PA., US, US , (20191106), vol. 46, doi:10.1016/j.smim.2019.101333, ISSN 1044-5323, XP085929924
OPPOSITION- Schett Georg, Mackensen Andreas, Mougiakakos Dimitrios, "CAR T-cell therapy in autoimmune diseases", The Lancet, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20231101), vol. 402, no. 10416, doi:10.1016/S0140-6736(23)01126-1, pages 2034 - 2044, XP093179243
OPPOSITION- Kochenderfer J N; Rosenberg S A, "Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors", NATURE REVIEWS CLINICAL ONCOLOGY, Nature, NY, US, NY, US , (20130501), vol. 10, no. 5, doi:10.1038/nrclinonc.2013.46, ISSN 1759-4774, pages 267 - 276, XP009170183
OPPOSITION- Schett Georg, Müller Fabian, Taubmann Jule, Mackensen Andreas, Wang Wei, Furie Rich A., Gold Ralf, Haghikia Aiden, Merkel Peter A., Caricchio Roberto, D’agostino Maria-Antonietta, Locatelli Franco, June Carl H., Mougiakakos Dimitrios, "Advancements and challenges in CAR T cell therapy in autoimmune diseases", Nature Reviews Rheumatology, Nature Publishing Group, GB, GB , (20240901), vol. 20, no. 9, doi:10.1038/s41584-024-01139-z, ISSN 1759-4790, pages 531 - 544, XP093280216
OPPOSITION- Porter David L; Levine Bruce L; Kalos Michael; Bagg Adam; June Carl H, "Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia", The New England journal of medicine, Massachusetts Medical Society, US, US , (20110825), vol. 365, no. 8, doi:10.1056/NEJMoa1103849, ISSN 0028-4793, pages 725 - 733, XP009510885
OPPOSITION- Ramos Carlos A., Savoldo Barbara, Dotti Gianpietro, "Author Manuscript: CD19-CAR Trials", CANCER JOURNAL, JONES AND BARTLETT PUBLISHERS, US, US , (20140301), vol. 20, no. 2, doi:10.1097/PPO.0000000000000031, ISSN 1528-9117, pages 1 - 12, XP093280191
OPPOSITION- P. E. Love, S. M. Hayes, "ITAM-mediated Signaling by the T-Cell Antigen Receptor", Cold Spring Harbor Perspectives in Biology, (20100601), vol. 2, no. 6, doi:10.1101/cshperspect.a002485, pages a002485 - a002485, XP055171927
OPPOSITION- Kalos M; Levine B L; Porter D L; Katz S; Grupp S A; Bagg A; June C H, "T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia", Science Translational Medicine(Supplementary Materials), American Association for the Advancement of Science, (20110810), vol. 3, no. 95, doi:10.1126/scitranslmed.3002842, ISSN 1946-6234, pages 95ra73.1 - 95ra73.11, XP002667262
OPPOSITION- M. Moeller, M. H. Kershaw, R. Cameron, J. A. Westwood, J. A. Trapani, M. J. Smyth, P. K. Darcy, "Sustained Antigen-Specific Antitumor Recall Response Mediated by Gene-Modified CD4+ T Helper-1 and CD8+ T Cells", Cancer research, American Association for Cancer Research, (20071201), vol. 67, no. 23, doi:10.1158/0008-5472.CAN-07-1141, ISSN 00085472, pages 11428 - 11437, XP055080756
OPPOSITION- R. J. Brentjens, E. Santos, Y. Nikhamin, R. Yeh, M. Matsushita, K. La Perle, A. Quintas-Cardama, S. M. Larson, M. Sadelain, "Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts", Clinical Cancer Research, Association for Cancer Research, (20070915), vol. 13, no. 18, doi:10.1158/1078-0432.CCR-07-0674, ISSN 10780432, pages 5426 - 5435, XP055204921
OPPOSITION- M. Sadelain, R. Brentjens, I. Riviere, "The Basic Principles of Chimeric Antigen Receptor Design", CANCER DISCOVERY, American Association for Cancer Research, US, US , (20130401), vol. 3, no. 4, doi:10.1158/2159-8290.CD-12-0548, ISSN 2159-8274, pages 388 - 398, XP055287277
OPPOSITION- Carolina Berger, Daniel Sommermeyer, Michael Hudecek, Michael Berger, Ashwini Balakrishnan, Paulina J. Paszkiewicz, Paula L. Kosasih, Christoph Rader, Stanley R. Riddell, "Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells", Cancer Immunology Research, American Association for Cancer Research, US, US , (20150201), vol. 3, no. 2, doi:10.1158/2326-6066.CIR-14-0163, ISSN 2326-6066, pages 206 - 216, XP055753214
OPPOSITION- LAPORT G G,ET AL, "Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.", Blood, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20030915), vol. 102, no. 6, doi:10.1182/blood-2003-01-0095, ISSN 0006-4971, pages 2004 - 2013, XP002316311
OPPOSITION- Li-Xin Wang, Shu Suyu, Disis Mary L, Plautz Gregory E, "Adoptive transfer of tumor-primed, in vitro activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response", Blood, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20070601), vol. 109, no. 11, doi:10.1182/blood-2006-09-045245, ISSN 0006-4971, pages 4865 - 4876, XP055649130
OPPOSITION- J. N. Kochenderfer, Z. Yu, D. Frasheri, N. P. Restifo, S. A. Rosenberg, "Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells", Blood, (20101111), vol. 116, no. 19, doi:10.1182/blood-2010-01-265041, ISSN 00064971, pages 3875 - 3886, XP055204922
OPPOSITION- R. J. Brentjens, I. Riviere, J. H. Park, M. L. Davila, X. Wang, J. Stefanski, C. Taylor, R. Yeh, S. Bartido, O. Borquez-Ojeda, M. Olszewska, Y. Bernal, H. Pegram, M. Przybylowski, D. Hollyman, Y. Usachenko, D. Pirraglia, J. Hosey, E. Santos, E. Halton, P. Maslak, D. Scheinberg, J. Jurcic, M. Heaney, G. Heller, M. Frattini, M. Sadelain, "Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias", Blood, (20111103), vol. 118, no. 18, doi:10.1182/blood-2011-04-348540, ISSN 00064971, pages 4817 - 4828, XP055169039
OPPOSITION- James N Kochenderfer , Mark E Dudley, Steven A Feldman, Wyndham H Wilson, David E Spaner, Irina Maric, Maryalice Stetler-Stevenson, Giao Q Phan, Marybeth S Hughes, Richard M Sherry, James C Yang, Udai S Kammula, Laura Devillier, Robert Carpenter, Debbie-Ann N Nathan, Richard A Morgan, Carolyn Laurencot, Steven A Rosenberg, "B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells", Blood, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20120322), vol. 119, no. 12, doi:10.1182/blood-2011-10-384388, ISSN 0006-4971, pages 2709 - 2720, XP055145503
OPPOSITION- Kochenderfer James N., Mark E Dudleysteven A Feldmanwyndham H Wilsondavid E Spaneririna Maricmaryalice Stetler-Stevensongiao Q Phanmarybeth S Hughesrichard M Sherryjames C Yangudai S Kammulalaura Devillierrobert Carpenterdebbie-Ann N Nathanrichard A Morgancarolyn Laurencotsteven A Rosenberg, "Supplemental data: B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells", Blood, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20120322), vol. 119, no. 12, doi:10.1182/blood-2011-10-384388, ISSN 0006-4971, pages 1 - 9, XP093280172
OPPOSITION- Sarah Catherine Walpole;David Prieto-Merino;Phil Edwards;John Cleland;Gretchen Stevens;Ian Roberts, "The weight of nations: an estimation of adult human biomass", BMC PUBLIC HEALTH, BIOMED CENTRAL, LONDON, GB, GB , (20120618), vol. 12, no. 1, doi:10.1186/1471-2458-12-439, ISSN 1471-2458, page 439, XP021132763
OPPOSITION- Chan-Juan Shen;Yu-Xiu Yang;Ethan Q Han;Na Cao;Yun-Fei Wang;Yi Wang;Ying-Ying Zhao;Li-Ming Zhao;Jian Cui;Puja Gupta;Albert J Wong;Shuang-Yin Han, "Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma", Journal of Hematology & Oncology, BioMed Central Ltd, London UK, London UK , (20130509), vol. 6, no. 1, doi:10.1186/1756-8722-6-33, ISSN 1756-8722, page 33, XP021151586
OPPOSITION- Mei Henrik E, Schmidt Stefanie, Dörner Thomas, "Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity", ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, GB , (20120101), vol. 14, no. Suppl 5, doi:10.1186/ar3909, ISSN 1478-6354, pages S1 - 16, XP093280235
OPPOSITION- Mcgonagle Dennis, Mcdermott Michael F, "A Proposed Classification of the Immunological Diseases", PLOS MEDICINE, Public Library of Science, US, US , (20060801), vol. 3, no. 8, doi:10.1371/journal.pmed.0030297, ISSN 1549-1676, pages e297 (1242) - 1248, XP093280213
OPPOSITION- Kim Young Dae, "Systemic autoinflammatory disorders: autoinflammatory and autoimmune disorders", Clinical and Experimental Pediatrics, (20231015), vol. 66, no. 10, doi:10.3345/cep.2023.00605, ISSN 2713-4148, pages 439 - 440, XP093280208
OPPOSITION- Kaegi Celine, Wuest Benjamin, Schreiner Jens, Steiner Urs C., Vultaggio Alessandra, Matucci Andrea, Crowley Catherine, Boyman Onur, "Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders", Frontiers in Immunology, Frontiers Media, Lausanne, CH, Lausanne, CH , (20190906), vol. 10, doi:10.3389/fimmu.2019.01990, ISSN 1664-3224, pages 1990 - 18, XP093280184
OPPOSITION- Carter Robert H., "B Cells in Health and Disease", Mayo Clinic Proceedings, Dowden Health Media, Inc, US, US , (20060301), vol. 81, no. 3, doi:10.4065/81.3.377, ISSN 0025-6196, pages 377 - 384, XP093280177
SEARCH- CHRISTIAN STEMBERGER ET AL, "Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting", PLOS ONE, (20120424), vol. 7, no. 4, doi:10.1371/journal.pone.0035798, page e35798, XP055043969 [X] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents